VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

Stock Comparison

WuXi AppTec Co., Ltd. vs Becton, Dickinson and Company

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

WuXi AppTec Co., Ltd.

603259 · Shanghai Stock Exchange

Market cap (USD)$37.4B
Gross margin (TTM)49.2%
Operating margin (TTM)42.7%
Net margin (TTM)41.7%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryCN
Data as of2026-05-01
Moat score
72/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into WuXi AppTec Co., Ltd.'s moat claims, evidence, and risks.

View 603259 analysis

Becton, Dickinson and Company

BDX · New York Stock Exchange

Market cap (USD)$53.1B
Gross margin (TTM)46.5%
Operating margin (TTM)10.6%
Net margin (TTM)5.3%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
Data as of2025-12-31
Moat score
66/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.

View BDX analysis

Comparison highlights

  • Moat score gap: WuXi AppTec Co., Ltd. leads (72 / 100 vs 66 / 100 for Becton, Dickinson and Company).
  • Segment focus: WuXi AppTec Co., Ltd. has 3 segments (84% in WuXi Chemistry); Becton, Dickinson and Company has 5 segments (29.5% in Medical Essentials).
  • Primary market structure: Competitive vs Competitive. Pricing power: Moderate vs Weak.
  • Moat breadth: WuXi AppTec Co., Ltd. has 5 moat types across 3 domains; Becton, Dickinson and Company has 7 across 3.

Primary market context

WuXi AppTec Co., Ltd.

WuXi Chemistry

Market

Global synthetic-molecule CRDMO services, including small-molecule discovery, process development, API manufacturing, peptides and oligonucleotides

Geography

Global, with major customer exposure to the United States, Europe and China

Customer

Large pharmaceutical companies, emerging biotechs and virtual pharma companies

Role

Integrated contract research, development and manufacturing partner across discovery, development and commercial manufacturing

Revenue share

84%

Becton, Dickinson and Company

Medical Essentials

Market

Single-use medical consumables and specimen collection systems

Geography

Global

Customer

Healthcare providers and clinical labs

Role

Manufacturer

Revenue share

29.5%

Side-by-side metrics

WuXi AppTec Co., Ltd.
Becton, Dickinson and Company
Ticker / Exchange
603259 - Shanghai Stock Exchange
BDX - New York Stock Exchange
Market cap (USD)
$37.4B
$53.1B
Gross margin (TTM)
49.2%
46.5%
Operating margin (TTM)
42.7%
10.6%
Net margin (TTM)
41.7%
5.3%
Sector
Healthcare
Healthcare
Industry
Medical - Diagnostics & Research
Medical - Instruments & Supplies
HQ country
CN
US
Primary segment
WuXi Chemistry
Medical Essentials
Market structure
Competitive
Competitive
Market share
6%-9% (implied)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Weak
Moat score
72 / 100
66 / 100
Moat domains
Supply, Demand, Legal
Demand, Supply, Legal
Last update
2026-05-01
2025-12-31

Moat coverage

Shared moat types

Design In QualificationCompliance AdvantageOperational Excellence

WuXi AppTec Co., Ltd. strengths

Scope EconomiesCapacity Moat

Becton, Dickinson and Company strengths

Installed Base ConsumablesData Workflow LockinLong Term ContractsSwitching Costs General

Segment mix

WuXi AppTec Co., Ltd. segments

Full profile >

WuXi Chemistry

Competitive

84%

WuXi Testing

Competitive

9.3%

WuXi Biology

Competitive

6.2%

Becton, Dickinson and Company segments

Full profile >

Medical Essentials

Competitive

29.5%

Connected Care

Oligopoly

20.9%

BioPharma Systems

Oligopoly

10.6%

Interventional

Competitive

23.9%

Life Sciences

Oligopoly

15.1%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.